Detalhe da pesquisa
1.
Spatially confined sub-tumor microenvironments in pancreatic cancer.
Cell
; 184(22): 5577-5592.e18, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644529
2.
Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity.
Immunity
; 55(2): 324-340.e8, 2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139353
3.
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer.
Nature
; 617(7959): 147-153, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36949200
4.
Hourglass, a rapid analysis framework for heterogeneous bioimaging data, identifies sex disparity in IL-6/STAT3-associated immune phenotypes in pancreatic cancer.
J Pathol
; 261(4): 413-426, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768107
5.
GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma.
Gut
; 72(3): 535-548, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36109153
6.
Systemic inflammatory prognostic scores in advanced pancreatic adenocarcinoma.
Br J Cancer
; 128(10): 1916-1921, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927977
7.
Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.
Gastroenterology
; 160(6): 2119-2132.e9, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33524400
8.
A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.
Nature
; 538(7625): 378-382, 2016 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27732578
9.
Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.
Gut
; 70(10): 1894-1903, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32933947
10.
Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer.
PLoS Comput Biol
; 15(1): e1006596, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30629588
11.
Erratum: A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.
Nature
; 542(7639): 124, 2017 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27851734
12.
WaveCNV: allele-specific copy number alterations in primary tumors and xenograft models from next-generation sequencing.
Bioinformatics
; 30(6): 768-74, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24192544
13.
Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells.
Nat Cancer
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448522
14.
Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC).
Front Genet
; 14: 1282824, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38028629
15.
Molecular characterisation of pancreatic ductal adenocarcinoma with NTRK fusions and review of the literature.
J Clin Pathol
; 76(3): 158-165, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34583947
16.
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancers.
NPJ Precis Oncol
; 7(1): 73, 2023 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558751
17.
Widespread hypertranscription in aggressive human cancers.
Sci Adv
; 8(47): eabn0238, 2022 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36417526
18.
Mitochondrial fitness and cancer risk.
PLoS One
; 17(10): e0273520, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36223343
19.
hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma.
Clin Cancer Res
; 28(23): 5115-5120, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36222851
20.
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma.
J Gastrointest Oncol
; 13(6): 3216-3226, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36636049